Navigation Links
Cepheid to Webcast Upcoming Financial Presentations
Date:8/9/2012

SUNNYVALE, Calif., Aug. 9, 2012 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via webcast.

Wedbush PacGrow Life Sciences Conference, New York, NY
Wednesday, August 15, 2012 at 10.20 a.m. Eastern Time

Baird Health Care Conference, New York, NY
Thursday, September 6, 2012 at 12.10 p.m. Eastern Time

Morgan Stanley Global Healthcare Conference, New York, NY
Wednesday, September 12, 2012 at 9.45 a.m. Eastern Time

UBS Global Life Sciences Conference, New York, NY
Thursday, September 20, 2012 at 9.30 a.m. Eastern Time

Credit Suisse Small & Mid Cap Conference, New York, NY
Friday, September 21, 2012 at 8.00 a.m. Eastern Time

Additionally, Cepheid announced that it will host an Analyst Event featuring management presentations and a question and answer session in New York, NY on Thursday, September 27, 2012 starting at 8.00 a.m. Eastern Time.  Attendance at the event is by invitation only, although Cepheid welcomes all interested parties to access the proceedings via a live audio webcast as detailed below.

Accessing Live Webcasts To access the live webcasts for these events, please visit Cepheid's website at http://ir.cepheid.com at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software.  A replay of the webcasts will be available shortly following the presentation and will remain available for at least 90 days.

About CepheidBased in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy to use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to access the full power of molecular diagnostics. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit www.cepheid.com.CONTACTS: For Media Inquiries: For Investor Inquiries:Jared Tipton

Jacquie Ross Cepheid Corporate Communications

Cepheid Investor RelationsTel: (408) 400-8377

Tel: (408) 400-8329communications@cepheid.com 

investor.relations@cepheid.com


'/>"/>
SOURCE Cepheid
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AcelRx Pharmaceuticals to Hold Second Quarter 2012 Financial Results Conference Call and Webcast on August 9, 2012
2. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
3. Pro-Dex, Inc. Announces Update Conference Call and Webcast
4. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
5. Cempra, Inc. to Report Second Quarter 2012 Financial and Operating Results, and Host Conference Call and Webcast on August 8, 2012
6. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
7. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
8. diaDexus, Inc. to Host Webcast August 7, 2012 on Second Quarter 2012 Financial Results
9. HeartWare Schedules Second Quarter Conference Call And Webcast
10. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2012 Financial Results On August 2, 2012
11. Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... Jan. 20, 2017  Palladian Health, a leading ... the launch of an opioid management program which ... opioids and helps stem the growing tide of ... to treat chronic non-cancer pain (back pain, neck ... and lack of evidence regarding long-term effectiveness. ...
(Date:1/20/2017)... VAE, January 20, 2017 ... Bedarf an Nothilfe   Die internationale humanitäre Stadt ... Hilfsgüter zu schaffen   Seine Hoheit ... der VAE sowie Herrscher von Dubai ... Stadt der Hilfe (International Humanitarian City IHC) zu verdreifachen, ...
(Date:1/19/2017)... LONDON , Jan. 19, 2017 ... 2022 Summary GlobalData,s new report, "Germany Cataract ... data on the Germany Cataract Surgery Devices market. The ... (in units) and average prices (USD) within market segements ... The report also provides company shares and distribution shares ...
Breaking Medicine Technology:
(Date:1/21/2017)... California (PRWEB) , ... January 21, 2017 , ... "ProDOF is the perfect set of ... subject to another subject in a scene," said Christina Austin - CEO of Pixel Film ... given scene. Easily create the illusion of a DSLR racking focus from one area ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... Dianne Travis-Teague, the electrifying line-up of events for its annual meeting “Coming Home ... and community. “Coming Home 2017” will be held on Friday January 27 ...
(Date:1/21/2017)... ... January 21, 2017 , ... In the United States, 20 million women ... of recovery, they often feel shame for having struggled with an eating disorder as ... the workshop, “Rising Strong in Life After an Eating Disorder” -- to be featured ...
(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between Goodwill® ... no longer use or need, from clothes to couches to dressers and bicycles. Roadie ... take them to the nearest Goodwill donation center through February 28th. , “January ...
(Date:1/20/2017)... ... January 20, 2017 , ... Doctor C LLC, a company based ... ECRM trade show to continue the marketing and distribution of its product, The Right ... providing 400 percent better absorption than traditional vitamin C supplements. At the trade show, ...
Breaking Medicine News(10 mins):